Review examines GLP-1 receptor agonists in male reproductive and urologic care
Authors in Translational Andrology and Urology survey how incretin therapy intersects with fertility, hormonal health and the perioperative urology setting.
PR
By Priya Raman · Science Reporter
Sep 29 20:00 ETSource: Translational andrology and urology
The wire
- 01A review published September 30 in Translational Andrology and Urology by Yellu, Kim, Wallace and colleagues covers GLP-1 receptor agonist use in male reproductive and perioperative urologic health.
- 02Urologists and prescribers increasingly see patients already on incretin therapy, raising questions about fertility counseling and management around surgery.
- 03This is a narrative review rather than new data; specific recommendations and their evidence grade would need to be read in the full text.
From the source
Read at pubmed.ncbi.nlm.nih.govExpanding the therapeutic potential of GLP-1 receptor agonists: implications for male reproductive and perioperative urologic health
Translational andrology and urology · 2026 Sep 30 · Yellu A, Kim JK, Wallace BK et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42866413/
